Haemonetics (HAE) EBITDA Margin Growth (3y) (2012 - 2026)
Haemonetics (HAE) EBITDA Margin Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.90 Bn | 194.30 Bn | 7.27 Bn | -201.00 |
| 2 | Stryker | 130.01 Bn | 126.54 Bn | 4.50 Bn | 586.00 |
| 3 | Medtronic | 120.53 Bn | 111.31 Bn | 6.41 Bn | 78.00 |
| 4 | Boston Scientific | 74.77 Bn | 74.24 Bn | 3.85 Bn | 736.00 |
| 5 | Edwards Lifesciences | 52.74 Bn | 48.49 Bn | 1.35 Bn | 887.00 |
| 6 | Dexcom | 34.74 Bn | 32.79 Bn | 830.00 Mn | 963.00 |
| 7 | GE HealthCare Technologies | 33.78 Bn | 31.67 Bn | 2.18 Bn | 212.00 |
| 8 | Koninklijke Philips | 26.43 Bn | 23.11 Bn | 4.55 Bn | 535.00 |
| 9 | Steris | 23.15 Bn | 22.67 Bn | 684.20 Mn | 244.00 |
| 10 | Haemonetics | 4.91 Bn | 4.69 Bn | 202.80 Mn | -31.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | -31.00 |
| Mar 28, 2026 | -1,823.00 |
| Dec 27, 2025 | 571.00 |
| Sep 27, 2025 | 216.00 |
| Jun 28, 2025 | 499.00 |
| Mar 29, 2025 | 1,433.00 |
| Dec 28, 2024 | 321.00 |
| Sep 28, 2024 | 475.00 |
| Jun 29, 2024 | 1,122.00 |
| Mar 30, 2024 | 1,813.00 |
| Dec 30, 2023 | -314.00 |
| Sep 30, 2023 | -1,696.00 |
| Jul 1, 2023 | 1,125.00 |
| Apr 1, 2023 | 68.00 |
| Dec 31, 2022 | -162.00 |
| Oct 1, 2022 | -398.00 |
| Jul 2, 2022 | 1,735.00 |
| Apr 2, 2022 | -232.00 |
| Jan 1, 2022 | 228.00 |
| Oct 2, 2021 | -58.00 |